Bowel (colorectal) cancer, Ovarian cancer, Prostate cancer, Secondary cancers, Stomach cancer, Womb (uterine or endometrial) cancer
Open
Phase 2
This trial is looking at a new drug called datopotamab deruxtecan (Dato Dxd) on its own, or with other treatments, for some . It is for people whose cancer has spread to nearby tissues or to another part of the body.
It is open for a number of different cancer types, to find out which look in ‘who can enter’.
Recruitment start: 6 February 2023
Recruitment end: 31 December 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Rebecca Kristeleit
AstraZeneca
Last reviewed: 16 July 2025
CRUK internal database number: 18801
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
